Replies to post #58528 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Apparently you did not read Highwayman's post.

[CherryTree1]

Well given the choice of believing you
or
Highwayman and LG (see his post)
who do you think we will pick?

Guessing you hadn't seen that post before making your allegation.

[highwayman4life]

Uh huh, sure ya betcha, righto, roger that, okidoki

[hope4patients]

Hey Adam,
Aren't you the guy that's been wrong on a lot of things biotech-related recently? Ok, thanks....just checking ;)

[TheFollower]

Adam, who exactly was the contact persons that you spoke to?
What are their names & their position within the companies?

Highwayman called Les Goldman - Senior Vice President, Business Development of Northwest Biotherapeutics

Also, have you called Les Goldman yourself, to confirm?

[HKBobby]

So BMS and Merck confirmed what Dr Prins said? That's fantastic, thanks Adam! Great news for NWBO.

And yes, it's not a 'partnership', nobody every thought that, you twat. Keep up the old 'pump and dump', I make lots of money doing the exact opposite of what you say! I'm a huge fan!!

[flipper44]

What AF said between the lines.

Merck and Bristol are informally involved in the planned DCVax-PD-1 Combo trial.

You realize, I suppose, that all three products are separately owned by three commercial companies -- NWBO owns DCVax-l, BMY owns Nivolomib, and MRK owns Keytruda.

[beartrap12]

Adam, Thank you for calling the two Pharmas and confirming that there is a combo-trial in the works for DCVax and PD-1 and that Merck and BMS also confirm that it's not a partnership, which some people on this board think might imply that NWBO, which owns the patent for DCVax, is giving up something. I know you expressed doubt at whether the trial would ever begin, but if we put your information from the big Pharmas together with what Dr. Prins confirmed to a roomful of doctors in March, we know negotiations are complete and the trial will start soon. If this is a Ph I trial, it makes sense that it would happen at UCLA only, no other hospitals. NWBO may not be investing any money because UCLA receives grants from many sources to fund its Ph I trials. But, of course, since NWBO owns DCVax, they (as in we who are invested) stand to benefit if the trial has positive results.
We also know, thanks to another contributor on this board, that NWBO owns the patent for just such a collaboration between immunotherapies. Dr. Prins of UCLA and Dr. Bosch of NWBO are both on the list of inventors, that also include NWBO CEO Linda Powers (who is an expert in writing patent laws; she helped European nations develop their patent laws), and UCLA brain surgeon and DCVax inventor Dr. Linda Liau. It is patent pending, from what I could find, and it was filed Nov. 5, 2014.
Thanks again for your input on this exciting news.
P.S.: Who would the "investigator" be, if not the parties involved?